GSK5533524
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK5533524, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors [Phase 1]